Channing Global Advisors, LLC Astrazeneca PLC Transaction History
Channing Global Advisors, LLC
- $131 Million
- Q3 2025
A detailed history of Channing Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Channing Global Advisors, LLC holds 10,092 shares of AZN stock, worth $902,224. This represents 0.59% of its overall portfolio holdings.
Number of Shares
10,092
Previous 9,724
3.78%
Holding current value
$902,224
Previous $679,000
13.99%
% of portfolio
0.59%
Previous 0.48%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...